نتایج جستجو برای: monotherapy hematopoietic

تعداد نتایج: 73323  

2015
Evgenii Germanovich Skurikhin Olga Victorovna Pershina Alena Mikhaylovna Reztsova Natalia Nikolaevna Ermakova Ekaterina Sergeevna Khmelevskaya Vycheslav Andreevich Krupin Inna Ernestovna Stepanova Andrew Vladimirovich Artamonov Andrew Alexandrovich Bekarev Pavel Gennadjevich Madonov Alexander Mikhaylovich Dygai

Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage...

Journal: :Journal of Antimicrobial Chemotherapy 2006

Journal: :Pediatric Neurology Briefs 2009

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Hans Reiser Jianying Wang Lee Chong William J Watkins Adrian S Ray Riri Shibata Gabriel Birkus Tomas Cihlar Sylvia Wu Bei Li Xiaohong Liu Ilana N Henne Grushenka H I Wolfgang Manoj Desai Gerald R Rhodes Arnold Fridland William A Lee William Plunkett David Vail Douglas H Thamm Robert Jeraj Daniel B Tumas

PURPOSE GS-9219, a novel prodrug of the nucleotide analogue 9-(2-phosphonylmethoxyethyl)guanine (PMEG), was designed as a cytotoxic agent that preferentially targets lymphoid cells. Our objective was to characterize the antiproliferative activity, pharmacokinetics, pharmacodynamics, and safety of GS-9219. EXPERIMENTAL DESIGN GS-9219 was selected through screening in proliferation assays and t...

Journal: :British Journal of Clinical Pharmacology 1984

2013
Teerha Piratvisuth Piyawat Komolmit Tawesak Tanwandee Wattana Sukeepaisarnjaroen Henry L. Y. Chan Mário G. Pessôa Eduardo Fassio Suzane K. Ono Fernando Bessone Jorge Daruich Stefan Zeuzem Hugo Cheinquer Rashidkhan Pathan Yuhong Dong Aldo Trylesinski

BACKGROUND AND AIMS The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety of this approach applied to telbivudine treatment has not been investigated. METHODS A multinational, phase IV, single-arm open-label study (ClinicalTrials.gov ID NCT00651209) was underta...

Journal: :British Journal of Psychiatry 1997

Journal: :Enfermedades infecciosas y microbiologia clinica 2016
Miriam Estébanez Jose I Bernardino Lucía Serrano Ignacio Pérez-Valero Francisco X Zamora Maria L Montes-Ramírez Juan J González-García Jose R Arribas

OBJECTIVE To evaluate the effect on creatinine clearance (CG-CrCl, Cockcroft-Gault equation) of switching to boosted protease inhibitor (PI) monotherapy in patients receiving a triple drug antiretroviral regimen containing TDF. METHODS All patients who had received a TDF-containing regimen for at least one year and had been switched to PI monotherapy were included. A rapid decrease in CG-CrCl...

Journal: :AIDS 2015
Andrea Antinori Amanda Clarke Veronika Svedhem-Johansson José R Arribas Alejandro Arenas-Pinto Jan Fehr Jan Gerstoft Andrzej Horban Bonaventura Clotet Diego Ripamonti Pierre-Marie Girard Andrew M Hill Christiane Moecklinghoff

BACKGROUND In previous studies in virologically suppressed patients, protease inhibitor monotherapy has shown trends for more low-level elevations in HIV-1 RNA compared with triple therapy, but no increase in the risk of drug resistance. METHODS A total of 273 patients with HIV-1 RNA less than 50 copies/ml on first-line antiretrovirals switched to darunavir/ritonavir (DRV/r) 800/100 mg once d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید